Malik Kemal
Insider CIK 1797921 · XLRN Director · RNAC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics, In | A Award deriv | 2026-01-02 | 2026-01-06 | 7,800 | — | $0 | 7,800 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2026-01-02 | 2026-01-06 | 2,600 | — | $0 | 11,133 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2025-01-02 | 2025-01-06 | 7,800 | — | $0 | 7,800 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2025-01-02 | 2025-01-06 | 2,600 | — | $0 | 8,533 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2024-07-01 | 2024-07-03 | 7,600 | — | $0 | 7,600 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2024-07-01 | 2024-07-03 | 5,933 | — | $0 | 5,933 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 17,956 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 3,222 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | U Tender | 2021-11-19 | 2021-11-22 | 1,622 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2021-01-29 | 2021-02-02 | 3,222 | — | $0 | 3,222 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2021-01-29 | 2021-02-02 | 1,622 | — | $0 | 1,622 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-02 | 2020-01-03 | 17,567 | — | $0 | 17,567 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-02 | 2020-02-10 | 17,956 | — | $0 | 17,956 | SEC↗ |